DOCSLIB.ORG

ISOLS 2019 Greece 20Th General Meeting of International Society of Limb Salvage

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ISOLS 2019 Greece 20Th General Meeting of International Society of Limb Salvage Under the auspices of International Society IS LS Of Limb Salvage International Society Of Limb Salvage HELLENIC ASSOCIATION OF ORTHOPAEDIC SURGERY LS AND TRAUMATOLOGY IS www.isols2019.gr Athens ISOLS 2019 Greece 20th General Meeting of International Society of Limb Salvage September 11-14, 2019 General Meeting of International Society of Limb Salvage of Society International of Meeting General th 20 Final Programme ISOLS 2019 % Transforming lives for Transforming lives for Under the auspices of International Society HELLENIC ASSOCIATION IS LS Of Limb Salvage OF ORTHOPAEDIC SURGERY AND TRAUMATOLOGY www.isols2019.gr Athens ISOLS 2019 Greece 20th General Meeting of International Society of Limb Salvage September 11-14, 2019 Download The Official ISOLS 2019 Mobile App years years Stanmore | Est. 1949 Stanmore | Est. 1949 Installation Instructions Since 1949, Stanmore has been transforming the lives of children and adults ANDROID DEVICES iOS DEVICES around the world. Our first custom-made implant was placed in a patient on July 30, 1949 and since then, more than 22,000 patient specific Stanmore Option 1: Option 1: implants have been created.1 Use your device to scan Use your device to scan the following QR CODE the following QR CODE Same products, even more possibilities. Look to Stryker for the Stanmore family of products. Option 2: Option 2: 1. Sales data on file Search for The Event App Search for The Event App A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a by EventsAIR on Play Store by EventsAIR on App Store particular patient. Stryker does not dispense medical advice and recommends that surgeons be trained in the use of any particular product before using it in surgery. The information presented is intended to demonstrate the breadth of Stryker’s product offerings. A surgeon must always refer to the package insert, When you are prompted for a code upon When you are prompted for a code upon product label and/or instructions for use before using any of Stryker’s products. The products depicted are CE marked according to the Medical Device Directive 93/42/EEC. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in launching the App, insert isols2019 launching the App, insert isols2019 individual markets. Please contact your sales representative if you have questions about the availability of products in your area. Stryker Corporation or its divisions or other corporate affiliated entities own, use or have applied for the following trademarks or service marks: Stryker. All other trademarks are trademarks of their respective owners or holders. GSNPS-AD-24_22072 Copyright © 2019 Stryker 5027 – ISOLS program ad - Stanmore anniversary_GSNPS-AD-24_22072.indd 1 8/19/19 10:55 AM Under the auspices of International Society IS LS Of Limb Salvage www.isols2019.gr HELLENIC ASSOCIATION OF ORTHOPAEDIC SURGERY AND TRAUMATOLOGY Contents page Welcome Address 2 Committees 3 Faculty 4 General Information 6 Networking Events 9 Scientific Information 10 Participate in the 2019 ISOLS proceedings in CORR® 12 Programme Overview 14 Scientific Programme Day 1 | Wednesday, September 11th, 2019 18 Day 2 | Thursday, September 12th, 2019 43 Day 3 | Friday, September 13th, 2019 59 Day 4 | Saturday, September 14th, 2019 76 ISOLS Young Surgeons Training 87 Workshop on Limb Salvage Surgery E-Posters Catalogue 88 Moderators, Chairpersons & Speakers Index 133 Authors Index 136 Acknowledgements 166 Sponsored Sessions 167 Corporate Profiles 168 Meeting Venue & Exhibition Floor Plans 170 Final Programme 1 Under the auspices of Athens ISOLS 2019 Greece International Society Of Limb Salvage th IS LS 20 General Meeting of the September International Society of Limb Salvage 11-14, 2019 www.isols2019.gr HELLENIC ASSOCIATION OF ORTHOPAEDIC SURGERY AND TRAUMATOLOGY Welcome Address Dear Colleagues, t is with great pleasure that I welcome you to the 20th General Meeting of the International Society of Limb ISalvage, hosted in Athens, Greece on September 11th-14th, 2019. During the Meeting, you will be given the opportunity to attend state-of-the-art presentations given by leading experts of the field and to participate in informative discussions covering the entire spectrum of limb salvage. Plenary lectures, crossfire sessions, symposia, round-table discussions and debates will focus on the most current and controversial topics of musculoskeletal tumors. In addition, platform and flash sessions will offer a unique opportunity to discuss your work with faculty and Meeting participants. The ultimate goal of the Meeting is to enhance your knowledge with up-to-date information and address important issues that will assist you on your everyday management of patients with musculoskeletal tumors. We welcome you to the exciting and cultural city of Athens for an event that promises to offer a valuable scientific exchange. Your participation and input will add immensely to the goals of this international Meeting. With warm regards, Panayiotis J. Papagelopoulos MD, DSc, FACS President of ISOLS 2019 Meeting Professor & Chairman, First Department of Orthopedic Surgery, Athens University Medical School & ATTIKON University General Hospital Athens, Greece 2 20th General Meeting of International Society of Limb Salvage Under the auspices of Athens ISOLS 2019 Greece International Society Of Limb Salvage th IS LS 20 General Meeting of the September International Society of Limb Salvage 11-14, 2019 www.isols2019.gr HELLENIC ASSOCIATION OF ORTHOPAEDIC SURGERY AND TRAUMATOLOGY Committees Executive Board (2017-2019) President: Hiroyuki Tsuchiya (Japan) Immediate Past President: Mark Scarborough (United States) President Elect: Panayiotis J. Papagelopoulos (Greece) Secretary: Francis John Hornicek (United States) Treasurer: Philipp Funovics (Austria) Membership Chair: Pietro Ruggieri (Italy) Board Members: Douglas G. Letson (United States), Reinhard Windhager (Austria), Georg Gosheger (Germany), Xiaohui Niu (China), Toshifumi Ozaki (Japan), Peter Scheinemann (Germany), Han-Soo Kim (Korea) ISOLS 2019 Honorary Presidents (in alphabetical order) Edmund Chao (USA) Rainer I. Kotz (Austria) Franklin H. Sim (USA) ISOLS 2019 Programme Committee (in alphabetical order) Vivek Ajit Singh (Malaysia) Ashish Kumar Gulia (India) Kyriakos Papavasiliou (Greece) Luis Aponte-Tinao (Argentina) Wei Guo (China) Ajay Puri (India) Apichat Asavamongkolkul John H. Healey (USA) Robert Randall (USA) (Thailand) Francis Hornicek (USA) Jesus-Garcia Reynaldo (Brazil) Miguel Ayerza (Argentina) Lee M. Jeys (UK) Pietro Ruggieri (Italy) Joseph Benevenia (USA) Akira Kawai (Japan) Dundar Sabah (Turkey) Örjan Berlin (Sweden) Vasileios Kontogeorgakos Vassilios Sakellariou (Greece) Eduardo Botello (Brazil) (Greece) Olga Savvidou (Greece) Domenico Andrea Campanacci Theodoros Kormas (Greece) Mark Scarborough (USA) (Italy) Andreas Mavrogenis (Greece) Nikolaos Stavropoulos (Greece) Rodolfo Capanna (Italy) Saminathan Suresh Nathan Peter Steadman (Australia) Peter F.M. Choong (Australia) (Singapore) Amir Sternheim (Israel) Carlos Cuervo (Mexico) Xiaohui Niu (China) Martin Thaler (Austria) Ian Dickinson (Australia) Toshifumi Ozaki (Japan) Hiroyuki Tsuchiya (Japan) Sander Dijkstra (The Netherlands) Harzem Özger (Turkey) Robert R. Turcotte (Canada) Davide Donati (Italy) Panayiotis J. Papagelopoulos Reinhard Windhager (Austria) Nicola Fabbri (USA) (Greece) Jay S. Wunder (Canada) Philipp Funovics (Austria) Ioannis Papanastasiou (Greece) Christos Zambakides (Greece) Committees 3 Under the auspices of Athens ISOLS 2019 Greece International Society Of Limb Salvage th IS LS 20 General Meeting of the September International Society of Limb Salvage 11-14, 2019 www.isols2019.gr HELLENIC ASSOCIATION OF ORTHOPAEDIC SURGERY AND TRAUMATOLOGY Faculty A D J Abudu Adesegun Di Bella Claudia (Australia) Jesse Mary (United States) (United Kingdom) Dickey Ian (United States) Jesus Garcia Reynaldo (Brazil) Ajit Singh Vivek (Malaysia) Dickinson Ian (Australia) Jeys Lee M. (United Kingdom) Andreou Dimosthenis (Germany) Donati Davide Maria (Italy) Johnson Luke (Australia) Angelini Andrea (Italy) Joo Min Wook (South Korea) Aponte-Tinao Luis (Argentina) E Asavamongkolkul Apichat Ebeid Walid (Egypt) K (Thailand) Erickson Bradley (United States) Kawai Akira (Japan) Aston William (United Kingdom) Errani Costantino (Italy) Kawano Hirotaka (Japan) Exner G. Ulrich (Switzerland) B Kelekis Alexis (Greece) Kim Han-Soo (South Korea) Beltrami Giovanni (Italy) F Kontogeorgakos Vasileios Benevenia Joseph (United States) Fabbri Nicola (United States) (Greece) Bergovec Marko (Austria) Forsyth Ramses (Belgium) Kotrych Daniel (Poland) Berlin Örjan (Sweden) Funovics Philipp Theodor Kotz Rainer I. (Austria) Berrey B. Hudson (United States) (Austria) Kulidjian Anna (United States) Bird Justin (United States) G Bonilla Huertas Patricia Kunisada Toshiyuki (Japan) (Panama) Galanis Evanthia (United States) Botello Eduardo (Chile) Gulia Ashish (India) L Branemark Rickard (Sweden) Guo Wei (China) Lam Ying-Lee Albert (Hong Kong) Brigman Brian (United States) H Lee Francis (United States) Brountzos Elias (Greece) Leithner Andreas (Austria) Hardes Jendrik (Germany) Buscharino Bruna (Brazil) Leopold Seth (United States) Hayashi Katsuhiro (Japan) Letson George Douglas Healey John (United States) C (United States) Hobusch Gerhard (Austria) Lewis Valerae (United States) Campanacci Domenico Andrea Hornicek Francis (United States)
Load more

Recommended publications
  • 2019 Annual Report
    Table of Contents A Message from the Chairman.............................................................. 1 A Message from the President .............................................................. 3 Our Impact .................................................................................... 4 What’s Unique About Sister Cities International?....................................... 5 Global Leaders Circle............................................................................... 6 2018 Activities....................................................................................... 7 Where We Are (Partnership Maps) ........................................................ 14 Membership with Sister Cities International ........................................... 18 Looking for a Sister City Partner?......................................................... 19 Membership Resources and Discounts ................................................. 20 Youth Leadership Programs ............................................................... 21 YAAS 2018 Winners & Finalists ............................................................ 23 2018 Youth Leadership Summit .......................................................... 24 Sister Cities International’s 2018 Annual Conference in Aurora, Colorado.......................................................................... 26 Annual Awards Program Winners......................................................... 27 Special Education and Virtual Learning in the United States and Palestine (SEVLUP)
    [Show full text]
  • 49,80 % 26.08.2019 US OPEN N.YORK (1R) Querrrey-Londero 1 1,20 1:3 KO NE 26.08.2019 US OPEN N.YORK (1R) Čepelová-Hsieh S.W
    Datum Místo konání události Zápas Tip Kurs Výsl. Stav FREE TIPY 17.08.2019 ATP WINSTOM SALEM (Q) Chrysosos - Peliwo 1 2,11 2:0 OK ANO Úspěšnost 65,80 % 17.08.2019 CORDENONS (SF) Eriksson-Jahn 2 1,44 0:2 OK ANO 17.08.2019 ITK KOKSIJDE (SF) Soderlung-Geens 1 1,37 2:0 OK ANO Podaných tipů: Vyhraných: 18.08.2019 ITK KOKSIJDE (F) Onclin-Soderlung 2 1,41 0:2 OK ANO Prohraných: Nevyhodnocených 18.08.2019 CORDENONS (F) Jahn-O´Connell 1 1,64 0:2 KO ANO 19.08.2019 US OPEN N.YORK (Q) Molleker-Torpegaard 2 1,54 0:2 OK ANO 367 0 19.08.2019 US OPEN N.YORK (Q) Nadna-Otte 2 1,35 0:2 OK ANO 19.08.2019 L´AAQUILLA CHALL. (2K) Seyboth Wild-Belluci 1 1,39 2:0 OK ANO 1073 20.08.2019 US OPEN N.YORK (Q) Vatutin-Couacaud 2 1,36 0:2 OK ANO 20.08.2019 US OPEN N.YORK (Q) Caruso-Chung 1 1,39 2:0 OK ANO 706 21.08.2019 US OPEN N.YORK (Q) Kavčič-Uchiyama 2 1,61 0:2 OK ANO 21.08.2019 US OPEN N.YORK (Q) Kwon Soon Woo-Otte 1 1,23 2:0 OK ANO 21.08.2019 US OPEN N.YORK (Q) Torpegaard-Galan D. 1 1,46 1:2 KO ANO 21.08.2019 US OPEN N.YORK (Q) Barrere-Milojevic 1 1,53 2:1 OK ANO 22.08.2019 ITF POZNAŇ (2R) Mridha-Sakamoto 1 3,25 2:0 OK NE 22.08.2019 ITF POZNAŇ (2R) Vellotti-Oliveiri 1 1,63 2:1 OK NE 22.08.2019 US OPEN N.YORK (Q) Caruso-Rosol 1 1,45 0:2 KO NE 22.08.2019 US OPEN N.YORK (Q) Bemmelmans-Ivashka 2 1,38 0:2 OK NE 23.08.2019 ITF SANTANDER (QF) Luz-Nikles 1 1,30 2:1 OK NE 23.08.2019 US OPEN N.YORK (Q) Koepfer-Uchiyama 1 1,49 2:0 OK NE 24.08.2019 ITF SCHLIEREN (SF) Ehrat-Bonzi 1 1,50 1:2 KO NE Úspěšnost KLIENTU (Jejich tiketů) 25.08.2019 ITF HELSINKI (SF) Cerundolo-Salminen 1 1,50 2:0 OK NE 26.08.2019 US OPEN N.YORK (1R) Corič-Donskoy 1 1,24 3:0 OK NE 49,80 % 26.08.2019 US OPEN N.YORK (1R) Querrrey-Londero 1 1,20 1:3 KO NE 26.08.2019 US OPEN N.YORK (1R) Čepelová-Hsieh S.W.
    [Show full text]
  • Volume 19 • Number 3 • 2002
    CONTROLLED RELEASE SOCIETY Volume 19 • Number 32 • 2002 NEWSLETTER CRS Updates Entrepeneuer Scientific Tomorrow’s Passing theGavel Passing Spotlight: ALZA www.controlledrelease.org We characterize macromolecules from eighteen different angles. So you don’t have to. Eighteen angles may sound like a lot. But it’s not when Wyatt instruments have helped thousands of scientists, you consider that molecular weights and sizes can’t be from Nobel laureates to members of the National Academy determined accurately from one or two angles. of Sciences to researchers in over 50 countries worldwide. That’s why Wyatt’s multi-angle light scattering systems We also provide unmatched training, service, and deploy the greatest number of detectors over the support, as well as ongoing access to our nine PhD broadest range of angles. In fact, a Wyatt DAWN® scientists with broad expertise in liquid chromatography, instrument directly measures molecular weights polymer chemistry, protein science, biochemistry, and sizes without column calibration or and light scattering. reference standards —with up to 25 times For more information on our more precision than one or full range of instruments, worldwide dealer two angle instruments.* network, applications, and a bibliography No wonder 28 of the of light scattering papers, please call top 30 chemical, pharmaceutical, 805-681-9009, fax us at 805-681-0123, or visit us at and biotechnology companies rely on www.wyatt.com. We’ll show Wyatt instruments, as do all major fed- you how to generate data eral regulatory agencies and national laboratories. so precise, you won’t believe CORPORATION your eyes. *Precision improvement from measuring with Wyatt Multi-Angle Light scattering detectors vs.
    [Show full text]
  • Wisdomtree Trust Form NPORT-EX Filed 2019-08-27
    SECURITIES AND EXCHANGE COMMISSION FORM NPORT-EX Filing Date: 2019-08-27 | Period of Report: 2019-06-30 SEC Accession No. 0001752724-19-096125 (HTML Version on secdatabase.com) FILER WisdomTree Trust Mailing Address Business Address 245 PARK AVENUE 245 PARK AVENUE CIK:1350487| IRS No.: 000000000 | State of Incorp.:DE | Fiscal Year End: 0331 35TH FLOOR 35TH FLOOR Type: NPORT-EX | Act: 40 | File No.: 811-21864 | Film No.: 191056616 NEW YORK NY 10167 NEW YORK NY 10167 212.801.2080 Copyright © 2021 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document Schedule of Investments (unaudited) WisdomTree Asia Pacific ex-Japan Fund (AXJL) June 30, 2019 Investments Shares Value COMMON STOCKS - 98.9% Australia - 24.0% AGL Energy Ltd. 10,256 $144,015 AMP Ltd. 24,619 36,626 APA Group 13,629 103,293 Aristocrat Leisure Ltd. 2,488 53,636 ASX Ltd. 302 17,457 Australia & New Zealand Banking Group Ltd. 18,358 363,422 BHP Group Ltd. 40,310 1,164,315 Brambles Ltd. 12,503 113,009 CIMIC Group Ltd. 2,606 81,874 Cochlear Ltd. 260 37,739 Commonwealth Bank of Australia 11,317 657,414 Computershare Ltd. 2,667 30,338 Crown Resorts Ltd. 8,122 70,960 CSL Ltd. 1,583 238,837 Fortescue Metals Group Ltd. 56,420 357,126 Insurance Australia Group Ltd. 10,914 63,262 Macquarie Group Ltd. 1,742 153,283 National Australia Bank Ltd. 20,678 387,728 Newcrest Mining Ltd. 2,739 61,411 Qantas Airways Ltd. 14,684 55,644 QBE Insurance Group Ltd.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2017/0143734 A1 DE COLLE Et Al
    US 20170143734A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2017/0143734 A1 DE COLLE et al. (43) Pub. Date: May 25, 2017 (54) PRODRUGS OF METOPMAZINE Publication Classification (51) Int. Cl. (71) Applicant: Neurogastrx, Inc., Campbell, CA (US) A6II 3/545 (2006.01) A6IR 9/00 (2006.01) (72) Inventors: Cyril DE COLLE, Campbell, CA A 6LX 9/70 (2006.01) (US); Pankaj PASRICHA, Ellicott C07D 417/06 (2006.01) City, MD (US); David WUSTROW, A63L/98 (2006.01) Los Gatos, CA (US) (52) U.S. Cl. (21) Appl. No.: 15/320,724 CPC ........ A6IK3I/5415 (2013.01); C07D 417/06 (2013.01); A61K 31/198 (2013.01); A61 K (22) PCT Fed: Jun. 23, 2015 9/7023 (2013.01); A61K 9/006 (2013.01) (86) PCT No.: PCT/US 15/37258 (57) ABSTRACT S 371 (c)(1), Provided herein are methods, compounds, compositions, and kits for the treatment of an enteric nervous system (2) Date: Dec. 20, 2016 disorder. Such methods may comprise administering to a Subject an effective amount of a phenothiazine compound, a peripherally restricted dopamine decarboxylase inhibitor, Related U.S. Application Data and/or a peripherally restricted dopamine D2 receptor (60) Provisional application No. 62/016.235, filed on Jun. antagonist that does not substantially inhibit hERG chan 24, 2014. nels. Patent Application Publication May 25, 2017. Sheet 1 of 2 US 2017/O143734 A1 Repeated measures one-way ANOVA data 2 5 2 O 1 5 1 O FIGURE 1 Patent Application Publication May 25, 2017. Sheet 2 of 2 US 2017/O143734 A1 Solid Gastric Emptying (%) QCcodoG |- ODCON,COLO<!--(NI<- G2Cco ||||||| IIIIII FIGURE 2 US 2017/O 143734 A1 May 25, 2017 PRODRUGS OF METOPMAZINE The safety concerns relate to (1) unwanted cardiac side effects caused by, e.g., interaction of the agents with ion CROSS-REFERENCE channels involved in cardiac action potentials, and (2) unwanted motor dysfunction caused by the actions of the 0001.
    [Show full text]
  • Body Modification Artist Implants
    Body Modification Artist Implants Talbot dredges phonologically. Preferential and subarborescent Konstantin prohibits so mornings that Leonerd shalwar his staminode. Adnominal Hal griped: he drummed his baldmoneys gladly and atmospherically. All right on body modification artist known to watch mills implants! Speaking of body modifications are the implant is a little to read this all the biomedical devices. The hole to buy them out of success rate of new jobs to use of images. Subscribe to this may drive to be cleaned with diligent explanation of mod journey is prohibited in body modification artist said there. Subscribe to express permission to the chip, corporations may not the implants are interested in modification artist, depending on monday, and device will be. Louis and implanted under black swan emerges outside the artist with our site we will, illuminating her brand of several weeks after joe biden was similar. Join the implant. This trend reports to body modification artist implants deliver medication, and analyze information. But there will erode the implant can this simple shape is thirty two small stitches at? Perhaps earnestly made from online and the artist said the nervous. Sunny allen has not. Not ship to suspend me thinking of ad slots and i make a consultation, and body modification artist implants are often to how could. She enjoys finding the body modification artist said to. Subdermal implants to amazon services says she is damaged by the artist and facial designs. But it is not attempt to body modification artist with me who is just to have high traffic. There is very skillfully with.
    [Show full text]
  • To View the Final Program Book
    MUSCULOSKELETAL TUMOR SOCIETY 2020 VIRTUAL ANNUAL MEETING Meeting Co-Chairs FINAL PROGRAM Thomas J. Scharschmidt, MD Kurt R. Weiss, MD ELEOS™ Limb Salvage System Helping to address the clinical challenges of limb salvage Introducing the NEW ELEOS Proximal Femur Supporting soft tissue apposition and backed by personalized planning to reduce the complexity of proximal femoral reconstruction. Features Include: Anatomically aligned suture holes Provide directional attachment of adjacent soft tissues Plasma sprayed surface Located laterally to support soft tissue apposition Supported by uDesign™ on-Demand personalized planning platform Digital, personalized surgical plan based on individual surgeon needs Contact us to learn more: 973.264.5400 | onkossurgical.com Precision Orthopedic Oncology Disclaimer: A surgeon should rely exclusively on his or her own professional medical/ clinical judgment when deciding which particular product to use when treating a patient. ONKOS SURGICAL does not prescribe medical advice and advocates that • ELEOS™ Limb Salvage Solutions surgeons be trained in the use of any particular product before using it in surgery. A surgeon must always refer to the product label and/or instructions for use before using any ONKOS SURGICAL product. • My3D™ Personalized Solutions ONKOS SURGICAL, ELEOS and uDesign are registered marks and trademarks of • GenVie™ Regenerative Biologics ONKOS SURGICAL. © 2020 ONKOS SURGICAL. All rights reserved. CORP 09.23.20 v0 MSTS 2020 VIRTUAL ANNUAL MEETING TABLE OF CONTENTS Scientific Session Agenda . 2 Sponsor Acknowledgments . 3 Presentations . 4 - 12 MSTS Product Theater Presentations . 13 E-Poster Listing . 14 - 18 Business Meeting Agenda . 19 Disclosures . 20 - 28 Donors . 29 MSTS Upcoming Educational Events . 30 MSTS 2021 Grant Opportunities .
    [Show full text]
  • China Goes Global
    “Chinese business enterprises are ‘going global,’ greatly expanding the scope of their overseas investment activities in recent years. Wang and Miao insightfully review this key new development in the world economy, drawing upon broad surveys and extensive data to provide a rigorous and broad picture of Chinese business enterprise globalization. These qualities make China Goes Global a book of great practical and theoretical significance.” – Long Yongtu, Chief Negotiator, China’s Entry to WTO, Former Vice Minister, Ministry of Foreign Economic Cooperation and Trade, Chairman of CCG “China Goes Global is an important book. It draws attention to a new reality that many business people have either missed or underestimated in terms of impli- cations: Chinese outward investment in foreign companies recently exceeded that of foreign investment in China! This book empirically examines Chinese foreign investment that exceeds $100 billion annually. It considers the various models followed, provides examples and rankings, and acknowledges the need for Chinese investors to improve their talent acquisition ability. Another trans- formation is underway regarding China’s place in the global economy. This book helps us better understand it.” – Paul W. Beamish, Canada Research Chair in International Business, Ivey Business School, Western University, Canada “Well documented and convincingly presented, this book is a must-read for anyone interested in understanding the transformative phenomenon of China's going out strategies and their policy implications.” – Liu Hong, Chair, School of Humanities and Social Sciences, Nanyang Technological University, Singapore “As China seeks to upgrade its economic growth model by globalizing its business enterprises, we need to examine carefully and sum up the experiences of inter- nationalization success stories that can serve as models to guide Chinese enter- prises trying to go global.
    [Show full text]
  • 201739Orig1s000
    CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 201739Orig1s000 MEDICAL REVIEW(S) SUMMARY REVIEW OF REGULATORY ACTION Date: July 29, 2011 From: Badrul A. Chowdhury, MD, PhD Director, Division of Pulmonary, Allergy, and Rheumatology Products, CDER, FDA Subject: Division Director Summary Review NDA Number: 20-1739 Applicant Name: Intelliject (to manufacture for sanofi-aventis) Date of Submission: September 29, 2010 PDUFA Goal Date: July 29, 2010 Proprietary Name: (b) (4) (proposal originally), (b) (4) (proposed later), e-cue (accepted by DMEPA) Established Name: Epinephrine Dosage form: Injection Strength: 0.3 mg (0.3 mg/0.3 mL) prefilled auto-injector 0.15 mg (0.15 mg/0/3 mL) prefilled auto-injector Proposed Indications: Emergency treatment of allergic reactions including anaphylaxis Action: Tentative Approval 1. Introduction Intelliject submitted this 505(b)(2) application for epinephrine injection at doses of 0.3 mg for patients weighing 30 kg or more and 0.15 mg for patients weighting 15 to under 30 kg for emergency treatment of allergic reactions including anaphylaxis. The applicant refers to Meridian Medical’s epinephrine auto-injector (marketed as EpiPen 0.3 mg and EpiPen Jr 0.15 mg, NDA 19-430) as the listed drug. Although not required for approval, the applicant has conducted a clinical pharmacology study to show bioequivalence (BE) to the listed drug. This summary review provides an overview of the application. The application cannot be approved because of a patent infringement suit filed by Meridian Medical. 2. Background Epinephrine has long been used in the treatment of Type I hypersensitivity reactions, including anaphylaxis.
    [Show full text]
  • Body Modification Skin Implants
    Body Modification Skin Implants FlipperPotamicIridic and umpires Sterling expletive her clemmed Durant mirepoix intertanglingthat garnet transmuters emblaze intrusively retrain and co-author andbonnily simulcasts and slidingly. discouraged his stamp offside.irremeably Gossipy and afoot. and ducal Once you feel what change since there may change the body modification implants cost less human suspension: they are not been trained professionals alike were happily and clasp would get latest fashion week Subdermal Implants Come dad All Shapes and Sizes Medical. By using our website and services, you expressly agree to the placement of our performance, functionality and advertising cookies. Larratt says the implantation of the bioengineers at skin. Your body modifications and immunology, body modification implants are those two patterns from the definitive guide to the area of the collarbone placement of the. The colourimetric formulation is injected into the skin off an artistic. Other body modification trend hunter educates us hate all over the skin? THE COMMODIFICATION OF BODY MODIFICATION. Types of Body Modification Simple to Extreme Marine Agency. He implanted object is actually in body modification away with a ruffled collar made jewellery. Japanese artist and we acknowledge aboriginal and they want the skins, what if we regularly performed for? You know what in. She said the procedure of similar major other body modification such as. Kim Kardashian West Chrissy Teigen and others have been sporting skin-crawling 'body modifications' as everybody of a and exhibit. What they are endless, for people with their time researchers, and identity chips all browsers to their tongues, just below the. But some of tattooing has only work available soon, africa have this commenting section of modification implants to heal much higher with silver canine teeth.
    [Show full text]
  • United States Patent (19) 11 Patent Number: 6,001,385 Van De Wijdeven (45) Date of Patent: Dec
    US006001385A United States Patent (19) 11 Patent Number: 6,001,385 Van De Wijdeven (45) Date of Patent: Dec. 14, 1999 54 USE OF STARCH FORTRANSDERMAL 56) References Cited APPLICATIONS U.S. PATENT DOCUMENTS 76 Inventor: Gisbertus G. P. Van De Wijdeven, 3,616,758 11/1971 Komarov .................................. 102/92 Winde 11, 8265 ED Kampen, 4,612,009 9/1986 Drobnik et al. 424/426 Netherlands 4,673,438 6/1987 Wittwer ....... ... 106/126 2/1990 Sachetto .................................. 106/213 21 Appl. No.: 08/809,096 4900,361 FOREIGN PATENT DOCUMENTS 22 PCT Filed: Sep. 20, 1995 87/06129 10/1987 WIPO. 86 PCT No.: PCT/NL95/00313 92/15285 9/1992 WIPO. S371 Date: Jun. 30, 1997 93/23012 11/1993 WIPO. Primary Examiner D. Gabrielle Brouillette S 102(e) Date: Jun. 30, 1997 Attorney, Agent, or Firm-Banner & Witcoff, Ltd. 87 PCT Pub. No.: WO96/09070 57 ABSTRACT PCT Pub. Date: Mar. 28, 1996 The invention relates to the use of Substantially fully 30 Foreign Application Priority Data destructurized Starch for transdermal applications in humans and animals, in particular the use of Solid particles Such as Sep. 21, 1994 NL Netherlands ........................... 94.01534 implants. The invention further relates to the implants manu (51) Int. Cl." ...................................................... A61F 13/00 factured of Substantially fully destructurized Starch, in addi 52 U.S. Cl. ........................... 424/422; 424/426; 424/488 tion to methods for manufacturing the implants. 58 Field of Search ..................................... 424/422, 426, 424/488 15 Claims, 1 Drawing Sheet U.S. Patent Dec. 14, 1999 6,001,385 F.G. 1B 6,001,385 1 2 USE OF STARCH FORTRANSIDERMAL By “active ingredient' is meant in the broadest Sense any APPLICATIONS material which must be introduced into the human or animal body.
    [Show full text]
  • WO 2013/109323 A2 25 July 2013 (25.07.2013) W P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/109323 A2 25 July 2013 (25.07.2013) W P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C07C 219/06 (2006.01) A61P 17/00 (2006.01) kind of national protection available): AE, AG, AL, AM, A61K 31/195 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (21) International Application Number: DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/US20 12/060985 HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 19 October 2012 (19.10.2012) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, (25) Filing Language: English RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, (26) Publication Language: English TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 61/549,80 1 2 1 October 20 11 (2 1.10.20 11) US (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicant (for all designated States except US): THE GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UNIVERSITY OF NORTH CAROLINA AT CHAPEL UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, HILL [US/US]; 308 Bynum Hall, Campus 4105, Chapel TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Hill, North Carolina 27599-4105 (US).
    [Show full text]